This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. AP-HP, Hôpital Corentin-Celton, DMU Psychiatrie et Addictologie, Service de Psychiatrie et d’Addictologie de l’adulte et du sujet âgé, Issy-les-Moulineaux, France
  2. Corresponding author: Valentin Scheer, MD, MPH, Department of Psychiatry, Corentin Celton Hospital, Paris Descartes University, 4 parvis Corentin Celton; 92130 Issy-les-Moulineaux, France ([email protected]).
  3. Université de Paris, AP-HP, Hôpital Corentin-Celton, DMU Psychiatrie et Addictologie, Service de Psychiatrie et d’Addictologie de l’adulte et du sujet âgé, Issy-les-Moulineaux, INSERM, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, Paris, France
  4. Division of Epidemiology, Services, and Prevention Research, National Institute on Drug Abuse, Bethesda, Maryland
  5. AP-HP, Hôpital Corentin-Celton, DMU Psychiatrie et Addictologie, Service de Psychiatrie et d’Addictologie de l’adulte et du sujet âgé, Issy-les-Moulineaux, France
  6. Université de Paris, AP-HP, Hôpital Hôtel-Dieu, DMU Psychiatrie et Addictologie, Service de Psychiatrie de l’adulte, INSERM, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, Paris, France
  7. Université de Paris, AP-HP, Hôpital Louis Mourier, Service de Psychiatrie, Colombes, INSERM, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, Paris, France
  8. Université de Paris, AP-HP, Hôpital Corentin-Celton, DMU Psychiatrie et Addictologie, Service de Psychiatrie et d’Addictologie de l’adulte et du sujet âgé, Issy-les-Moulineaux, INSERM, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, Paris, France
  1. Grant BF, Hasin DS, Stinson FS, et al. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry. 2006;67(3):363–374. PubMed CrossRef
  2. Hollifield M, Katon W, Skipper B, et al. Panic disorder and quality of life: variables predictive of functional impairment. Am J Psychiatry. 1997;154(6):766–772. PubMed CrossRef
  3. Bringager CB, Friis S, Arnesen H, et al. Nine-year follow-up of panic disorder in chest pain patients: clinical course and predictors of outcome. Gen Hosp Psychiatry. 2008;30(2):138–146. PubMed CrossRef
  4. Krieg J-C, Bronisch T, Wittchen H-U, et al. Anxiety disorders: a long-term prospective and retrospective follow-up study of former inpatients suffering from an anxiety neurosis or phobia. Acta Psychiatr Scand. 1987;76(1):36–47. PubMed CrossRef
  5. Carpiniello B, Baita A, Carta MG, et al. Clinical and psychosocial outcome of patients affected by panic disorder with or without agoraphobia: results from a naturalistic follow-up study. Eur Psychiatry. 2002;17(7):394–398. PubMed CrossRef
  6. Coryell W, Endicott J, Andreasen NC, et al. Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry. 1988;145(3):293–300. PubMed CrossRef
  7. Sibrava NJ, Beard C, Bjornsson AS, et al. Two-year course of generalized anxiety disorder, social anxiety disorder, and panic disorder in a longitudinal sample of African American adults. J Consult Clin Psychol. 2013;81(6):1052–1062. PubMed CrossRef
  8. Andersch S, Hetta J. A 15-year follow-up study of patients with panic disorder. Eur Psychiatry. 2003;18(8):401–408. PubMed CrossRef
  9. Albus M, Scheibe G. Outcome of panic disorder with or without concomitant depression: a 2-year prospective follow-up study. Am J Psychiatry. 1993;150(12):1878–1880. PubMed CrossRef
  10. Ehlers A. A 1-year prospective study of panic attacks: clinical course and factors associated with maintenance. J Abnorm Psychol. 1995;104(1):164–172. PubMed CrossRef
  11. Angst J. Panic disorder: history and epidemiology. Eur Psychiatry. 1998;13(suppl 2):51s–55s. PubMed CrossRef
  12. Mavissakalian MR, Guo S. Early detection of relapse in panic disorder. Acta Psychiatr Scand. 2004;110(5):393–399. PubMed CrossRef
  13. Svanborg C, Bäärnhielm S, Åberg Wistedt A, et al. Helpful and hindering factors for remission in dysthymia and panic disorder at 9-year follow-up: a mixed methods study. BMC Psychiatry. 2008;8(1):52. PubMed CrossRef
  14. Swoboda H, Amering M, Windhaber J, et al. The long-term course of panic disorder–an 11 year follow-up. J Anxiety Disord. 2003;17(2):223–232. PubMed CrossRef
  15. Liu Y, Sareen J, Bolton J, et al. Development and validation of a risk-prediction algorithm for the panic disorder: a prediction algorithm for the recurrence of panic disorder. Depress Anxiety. PubMed CrossRef
  16. Batelaan NM, de Graaf R, Penninx BWJH, et al. The 2-year prognosis of panic episodes in the general population. Psychol Med. 2010;40(1):147–157. PubMed CrossRef
  17. Warshaw MG, Massion AO, Shea MT, et al. Predictors of remission in patients with panic with and without agoraphobia: prospective 5-year follow-up data. J Nerv Ment Dis. 1997;185(8):517–519. PubMed CrossRef
  18. Seguí J, Márquez M, García L, et al. Differential clinical features of early-onset panic disorder. J Affect Disord. 1999;54(1-2):109–117. PubMed CrossRef
  19. Ramsawh HJ, Weisberg RB, Dyck I, et al. Age of onset, clinical characteristics, and 15-year course of anxiety disorders in a prospective, longitudinal, observational study. J Affect Disord. 2011;132(1-2):260–264. PubMed CrossRef
  20. Batelaan NM, de Graaf R, Spijker J, et al. The course of panic attacks in individuals with panic disorder and subthreshold panic disorder: a population-based study. J Affect Disord. 2010;121(1-2):30–38. PubMed CrossRef
  21. Benítez CI, Shea MT, Raffa S, et al. Anxiety sensitivity as a predictor of the clinical course of panic disorder: a 1-year follow-up study. Depress Anxiety. 2009;26(4):335–342. PubMed CrossRef
  22. Nay W, Brown R, Roberson-Nay R. Longitudinal course of panic disorder with and without agoraphobia using the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychiatry Res. 2013;208(1):54–61. PubMed CrossRef
  23. Roy-Byrne PP, Cowley DS. Course and outcome in panic disorder: a review of recent follow-up studies. Anxiety. 1994-1995;1(4):151–160. PubMed CrossRef
  24. Ansell EB, Pinto A, Edelen MO, et al. The association of personality disorders with the prospective 7-year course of anxiety disorders. Psychol Med. 2011;41(5):1019–1028. PubMed CrossRef
  25. Roy-Byrne PP, Geraci M, Uhde TW. Life events and the onset of panic disorder. Am J Psychiatry. 1986;143(11):1424–1427. PubMed CrossRef
  26. Moitra E, Dyck I, Beard C, et al. Impact of stressful life events on the course of panic disorder in adults. J Affect Disord. 2011;134(1-3):373–376. PubMed CrossRef
  27. Rodriguez BF, Bruce SE, Pagano ME, et al. Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depression. J Anxiety Disord. 2005;19(7):752–766. PubMed CrossRef
  28. Katschnig H, Amering M, Stolk JM, et al. Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry. 1995;167(4):487–494. PubMed CrossRef
  29. Blanco C, Krueger RF, Hasin DS, et al. Mapping common psychiatric disorders: structure and predictive validity in the national epidemiologic survey on alcohol and related conditions. JAMA Psychiatry. 2013;70(2):199–208. PubMed CrossRef
  30. Eaton NR, Keyes KM, Krueger RF, et al. An invariant dimensional liability model of gender differences in mental disorder prevalence: evidence from a national sample. J Abnorm Psychol. 2012;121(1):282–288. PubMed CrossRef
  31. Hoertel N, Franco S, Wall MM, et al. Mental disorders and risk of suicide attempt: a national prospective study. Mol Psychiatry. 2015;20(6):718–726. PubMed CrossRef
  32. Hoertel N, McMahon K, Olfson M, et al. A dimensional liability model of age differences in mental disorder prevalence: evidence from a national sample. J Psychiatr Res. 2015;64:107–113. PubMed CrossRef
  33. Franco S, Olfson M, Wall MM, et al. Shared and specific associations of substance use disorders on adverse outcomes: a national prospective study. Drug Alcohol Depend. 2019;201:212–219. PubMed CrossRef
  34. de Raykeer R, Hoertel N, Blanco C, et al. Effects of psychiatric disorders on suicide attempt: similarities and differences between older and younger adults in a national cohort study. J Clin Psychiatry. 2018;79(6):17m11911. PubMed CrossRef
  35. Hoertel N, Blanco C, Olfson M, et al. A comprehensive model of predictors of suicide attempt in depressed individuals and effect of treatment-seeking behavior: results from a national 3-year prospective study. J Clin Psychiatry. 2018;79(5):17m11704. PubMed CrossRef
  36. Hoertel N, Faiz H, Airagnes G, et al. A comprehensive model of predictors of suicide attempt in heavy drinkers: results from a national 3-year longitudinal study. Drug Alcohol Depend. 2018;186:44–52. PubMed CrossRef
  37. Hoertel N, Rotenberg L, Blanco C, et al; CSA Study group. A comprehensive model of predictors of quality of life in older adults with schizophrenia: results from the CSA study. Soc Psychiatry Psychiatr Epidemiol. 2021;56(8):1411–1425. PubMed CrossRef
  38. Hoertel N, Rotenberg L, Blanco C, et al; CSA Study Group. Psychiatric symptoms and quality of life in older adults with schizophrenia spectrum disorder: results from a multicenter study. Eur Arch Psychiatry Clin Neurosci. 2020;270(6):673–688. PubMed CrossRef
  39. Grant BF, Goldstein RB, Chou SP, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2009;14(11):1051–1066. PubMed CrossRef
  40. Canino G, Bravo M, Ramírez R, et al. The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J Stud Alcohol. 1999;60(6):790–799. PubMed CrossRef
  41. Grant BF, Dawson DA, Stinson FS, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71(1):7–16. PubMed CrossRef
  42. Ware JE. Kosinski M, Turner-Bowker DM, et al. How to Score Version 2 of the SF-12 Health Survey. Lincoln, RI: Quality Metrics; 2002.
  43. Rubio JM, Olfson M, Pérez-Fuentes G, et al. Effect of first episode axis I disorders on quality of life. J Nerv Ment Dis. 2014;202(4):271–274. PubMed CrossRef
  44. Rubio JM, Olfson M, Villegas L, et al. Quality of life following remission of mental disorders: findings from the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry. 2013;74(5):e445–e450. PubMed CrossRef
  45. Caspi A, Houts RM, Belsky DW, et al. The p Factor: one general psychopathology factor in the structure of psychiatric disorders? Clin Psychol Sci. 2014;2(2):119–137. PubMed CrossRef
  46. Wall MM, Li R. Comparison of multiple regression to two latent variable techniques for estimation and prediction. Stat Med. 2003;22(23):3671–3685. PubMed CrossRef
  47. Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry. 1999;56(10):921–926. PubMed CrossRef
  48. Greene AL, Eaton NR. Panic disorder and agoraphobia: a direct comparison of their multivariate comorbidity patterns. J Affect Disord. 2016;190:75–83. PubMed CrossRef
  49. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–627. PubMed CrossRef
  50. Wittchen H-U, Gloster AT, Beesdo-Baum K, et al. Agoraphobia: a review of the diagnostic classificatory position and criteria. Depress Anxiety. 2010;27(2):113–133. PubMed CrossRef
  51. Drenckhan I, Glöckner-Rist A, Rist F, et al. Dimensional structure of bodily panic attack symptoms and their specific connections to panic cognitions, anxiety sensitivity and claustrophobic fears. Psychol Med. 2015;45(8):1675–1685. PubMed CrossRef
  52. Rappaport LM, Moskowitz DS, Galynker I, et al. Panic symptom clusters differentially predict suicide ideation and attempt. Compr Psychiatry. 2014;55(4):762–769. PubMed CrossRef
  53. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model Multidiscip J. 1999;6(1):1–55. CrossRef
  54. Muthen LK, Muthen BO. Mplus User’s Guide. Los Angeles, CA: Muthén & Muthén; 1998.
  55. Simon GE, VonKorff M. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area study. Am J Psychiatry. 1991;148(11):1494–1500. PubMed CrossRef
  56. Chen Y-H, Chen S-F, Lin H-C, et al. Healthcare utilization patterns before and after contact with psychiatrist care for panic disorder. J Affect Disord. 2009;119(1–3):172–176. PubMed CrossRef
  57. Blanco C, Wall MM, Hoertel N, et al. Psychiatric disorders and risk for multiple adverse outcomes: a national prospective study. Mol Psychiatry. 2021;26(3):907–916. PubMed CrossRef
  58. Goodwin RD, Lieb R, Hoefler M, et al. Panic attack as a risk factor for severe psychopathology. Am J Psychiatry. 2004;161(12):2207–2214. PubMed CrossRef
  59. Cowley DS, Flick SN, Roy-Byrne PP. Long-term course and outcome in panic disorder: a naturalistic follow-up study. Anxiety. 1996;2(1):13–21. PubMed CrossRef
  60. Lecrubier Y. The impact of comorbidity on the treatment of panic disorder. J Clin Psychiatry. 1998;59(suppl 8):11–14, discussion 15–16. PubMed
  61. Blanco C, Okuda M, Wang S, et al. Testing the drug substitution switching-addictions hypothesis. a prospective study in a nationally representative sample. JAMA Psychiatry. 2014;71(11):1246–1253. PubMed CrossRef
  62. Blanco C, Wall MM, Wang S, et al. Examining heterotypic continuity of psychopathology: a prospective national study. Psychol Med. 2017;47(12):2097–2106. PubMed CrossRef
  63. Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA. 2010;303(19):1921–1928. PubMed CrossRef
  64. Wang Y-J, Chung C-P, Sheng W-Y, et al. Cerebral autoregulation in panic disorder. J Psychiatr Res. 2010;44(16):1246–1248. PubMed CrossRef
  65. Shioiri T, Kojima M, Hosoki T, et al. Momentary changes in the cardiovascular autonomic system during mental loading in patients with panic disorder: a new physiological index “rho(max)”. J Affect Disord. 2004;82(3):395–401. PubMed CrossRef
  66. Chen Y-H, Lin H-C. Patterns of psychiatric and physical comorbidities associated with panic disorder in a nationwide population-based study in Taiwan. Acta Psychiatr Scand. 2011;123(1):55–61. PubMed CrossRef
  67. Birchall H, Brandon S, Taub N. Panic in a general practice population: prevalence, psychiatric comorbidity and associated disability. Soc Psychiatry Psychiatr Epidemiol. 2000;35(6):235–241. PubMed CrossRef
  68. Perna G, Caldirola D, Bellodi L. Panic disorder: from respiration to the homeostatic brain. Acta Neuropsychiatr. 2004;16(2):57–67. PubMed CrossRef
  69. Kahn JP, Drusin RE, Klein DF. Idiopathic cardiomyopathy and panic disorder: clinical association in cardiac transplant candidates. Am J Psychiatry. 1987;144(10):1327–1330. PubMed CrossRef
  70. Schmidt NB, Telch MJ. Nonpsychiatric medical comorbidity, health perceptions, and treatment outcome in patients with panic disorder. Health Psychol. 1997;16(2):114–122. PubMed CrossRef
  71. Pohl R, Yeragani VK, Balon R, et al. Isoproterenol-induced panic attacks. Biol Psychiatry. 1988;24(8):891–902. PubMed CrossRef
  72. Perna G, Caldirola D. Is panic disorder a disorder of physical fitness? a heuristic proposal. F1000 Res. 2018;7:294. PubMed CrossRef
  73. Lambert EA, Thompson J, Schlaich M, et al. Sympathetic and cardiac baroreflex function in panic disorder. J Hypertens. 2002;20(12):2445–2451. PubMed CrossRef
  74. Aronson TA, Logue CM. On the longitudinal course of panic disorder: development history and predictors of phobic complications. Compr Psychiatry. 1987;28(4):344–355. PubMed CrossRef
  75. Keller MB, Hanks DL. Course and outcome in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 1993;17(4):551–570. PubMed CrossRef